MS Pharma’s subsidiary El Kendi is the leading generic pharmaceutical manufacturing company in Algeria. 

The local manufacturing site supplies the Algerian market with more than 175 different products covering the fundamental therapeutic classes. 

The Algerian site can manufacture different pharmaceutical dosage forms, such as solids, semi-solids, and liquids. Additionally, the company is investing in augmenting its portfolio with injectables and biosimilar medications.

MS Pharma has two manufacturing sites in Jordan.

UPM: The company’s subsidiary United Pharmaceuticals (UPM) has been manufacturing a wide range of pharmaceutical products for the local market and 20 countries worldwide since 1989.

UPM was the first pharmaceutical company in the region to receive a European GMP (Good Manufacturing Practice) certificate.

With more than 260 brands, and dosage forms from oral solids, semisolids, and liquids in various therapeutic areas, UPM plays a significant role in the region.

MSPI: MS Pharma Injectables (MSPI) focuses on manufacturing a comprehensive and diversified portfolio of sterile medications, with more than 100 products in different therapeutic areas (hematology, central nervous system, systemic anti-infective, musculoskeletal, gastrointestinal tract, and oncology). The site is expanding with a new sterile vial line.